Avalon GloboCare’s Subsidiary Accepted into AMD AI Developer Program to Advance Next-Generation Media Infrastructure
Rhea-AI Summary
Avalon GloboCare (NASDAQ: ALBT) was accepted into the AMD AI Developer Program on Feb. 26, 2026, giving its AI subsidiary AQAI access to AMD Developer Cloud credits, tools, training, and community resources.
Avalon plans to use AMD Instinct accelerators and EPYC processors to speed model training, inference, and scalability for automated evidence-constrained video generation, AI-assisted drafting, compliance tooling, and workflow automation.
Positive
- None.
Negative
- None.
News Market Reaction – ALBT
On the day this news was published, ALBT gained 114.48%, reflecting a significant positive market reaction. Argus tracked a peak move of +177.1% during that session. Our momentum scanner triggered 54 alerts that day, indicating high trading interest and price volatility. This price movement added approximately $4M to the company's valuation, bringing the market cap to $7M at that time. Trading volume was exceptionally heavy at 497.1x the daily average, suggesting very strong buying interest.
Data tracked by StockTitan Argus on the day of publication.
Market Reality Check
Peers on Argus
ALBT is up 1.38% with modest volume. Sector scanner shows LRHC and RFL also moving up (around 3–5%), while DUO is down. With 2 peers in the same direction and no peer-specific news, the move appears partly sector-driven.
Previous AI Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 18 | AI patent filing | Positive | -16.1% | Third U.S. provisional patent for Catch-Up generative AI video platform. |
| Jan 22 | AI patent filing | Positive | +1.6% | Provisional patent for evidence-constrained, audience-adaptive commentary videos. |
| Jan 20 | Product & AI launch | Positive | -6.0% | FDA registration renewal for KetoAir and planned AI-driven B2B/B2C launch. |
| Jan 12 | Nasdaq compliance & AI | Positive | -10.2% | Regained Nasdaq equity compliance and began marketing AI video platform. |
| Dec 30 | AI platform highlight | Positive | -6.0% | Acquisition of RPM Interactive and promotion of Catch-Up AI video platform. |
Recent AI-related announcements have often been followed by negative 24h moves, even when operationally positive.
Over the last few months, Avalon has focused on AI-driven media infrastructure and compliance-ready automated video commentary. Key steps include regaining Nasdaq equity compliance, acquiring and promoting the Catch-Up generative AI video platform, and filing multiple U.S. provisional patents for audience-adaptive, evidence-constrained video systems. These AI-tagged releases (spanning Dec 30, 2025 to Feb 18, 2026) frequently saw negative next-day price reactions, suggesting cautious market reception to the AI pivot despite consistent execution updates.
Historical Comparison
In the past 5 AI-tagged updates, ALBT’s average 24h move was -7.33%, with four negative reactions despite constructive AI platform and patent milestones.
AI-tagged news shows a progression from highlighting the Catch-Up AI video platform and RPM acquisition, to regaining Nasdaq compliance, then filing successive provisional patents for audience-adaptive, evidence-constrained commentary systems.
Market Pulse Summary
The stock surged +114.5% in the session following this news. A strong positive reaction aligns with Avalon’s ongoing shift toward AI-driven media infrastructure. The company has repeatedly highlighted AQAI’s role and filed multiple AI-related patents, yet prior AI announcements saw an average -7.33% 24h move. A sharp upside move could therefore reflect changing sentiment but might also be vulnerable if financing needs, prior volatility, or profit-taking pressures reassert themselves.
Key Terms
generative ai technical
ai developer program technical
multimodal ai systems technical
workflow automation technical
AI-generated analysis. Not financial advice.
Strategic Access to AMD Developer Cloud Expected to Accelerate High-Performance AI Video Generation, and Future Enterprise Automation and Scalable Deployment
FREEHOLD, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced that it has been accepted into the Advanced Micro Devices (“AMD”) AI Developer Program, providing the Company with access to AMD Developer Cloud credits, advanced tools, training, and community resources designed to support and accelerate artificial intelligence development.
Avalon intends to leverage these resources primarily through its AI-driven subsidiary, Avalon Quantum AI LLC (“AQAI”), as the Company continues scaling its automated commentary video generation systems, and future planned enterprise documentation tools, and AI-powered workflow automation platform.
Participation in the AMD AI Developer Program provides Avalon with access to high-performance compute resources powered by AMD Instinct™️ accelerators and EPYC™️ processors via AMD Developer Cloud. These capabilities are expected to enhance model training efficiency, inference speed, and scalability of large language and multimodal AI systems powering AQAI’s platform.
AQAI is focused on developing AI systems capable of:
- Automated, evidence-constrained commentary video generation
- AI-assisted drafting for public company communications
- Enterprise-grade compliance and workflow automation
- Adaptive content generation tailored to audience-specific requirements
“Acceptance into the AMD AI Developer Program reinforces AQAI’s technical capabilities as we expand our AI-driven media and automation platforms,” said Meng Li, Avalon’s Interim Chief Executive Officer and Chief Operating Officer. “Avalon has been strategically repositioning itself as a technology-focused AI company, with AQAI serving as a core growth driver in automated media production and enterprise AI applications.”
About AMD AI Developer Program
The AMD AI Developer Program provides participants access to AMD Developer Cloud resources, computing infrastructure, training materials, and community support to assist in developing and optimizing AI applications. Participation in the program consists of enrollment in AMD’s developer ecosystem, which is offered without charge and is generally available to developers interested in building or optimizing AI projects using AMD technology.
About Avalon GloboCare Corp.
Avalon GloboCare Corp. (NASDAQ: ALBT) is a technology-focused company developing and acquiring innovative artificial intelligence platforms. Through its AI-driven subsidiary, Avalon Quantum AI LLC, the Company is advancing next-generation AI systems, including automated video generation, enterprise documentation, and workflow automation solutions. Avalon is also expanding its intellectual property portfolio in cellular therapy and generative AI publishing and software. In addition, Avalon is marketing the KetoAir™ breathalyzer device, which is registered with the U.S. Food and Drug Administration as a Class I medical device, and plans to pursue additional diagnostic applications for the technology.
For more information about Avalon, please visit www.avalon-globocare.com. Information on the Company’s website does not constitute a part of and is not incorporated by reference into this press release.
Forward-Looking Statements
Certain statements contained in this press release are “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve several risks and uncertainties. You can identify these statements by the fact that they use words such as “will”, “anticipate”, “estimate”, “expect”, “should”, “may”, and other words and terms of similar meaning or use of future dates; however, the absence of these words or similar expressions does not mean that a statement is not forward-looking. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact, including statements regarding the ability to enter into a definitive agreement, as well as the Company’s commercialization, distribution and sales of its products and the product’s ability to compete with other similar products. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the SEC, accessible through the SEC’s website (http://www.sec.gov), including our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K filed or furnished with the SEC. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors, including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. The Company disclaims any obligation to update forward-looking statements. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release. The contents of any website referenced in this press release are not incorporated by reference herein.
Contact Information:
Avalon GloboCare Corp.
4400 Route 9 South, Suite 3100
Freehold, NJ 07728
PR@Avalon-GloboCare.com
Investor Relations:
Crescendo Communications, LLC
Tel: (212) 671-1020 Ext. 304
albt@crescendo-ir.com